Key dates
Registration and abstract submission open on 6 May 2019.
Other key dates: Abstract submission closes 6 September (9 AM CET)
Online registration closes 6 November (12 PM CET)
Preliminary programme: sessions, speaker and preliminary titles
- Keynote (Cure) Keynote: Dr. Anthony Fauci (NIH/NIAID, Bethesda, USA), title to be confirmed
- Plenary (Treatment): Prof. Chloe Orkin (Barts Health NHS Trust, London, UK), ART: a changing landscape
- Plenary (Epidemiology): Dr. Karoline Aebi-Popp (University Hospital Bern, Switzerland), Challenges and needs for women living with HIV: From conception to infancy
- Plenary (Prevention): Prof. Waafa El Sadr (Columbia University, New York, USA), Combination HIV prevention from the global north to the global south
Please note: titles of plenary talks are subject to change
In line with previous years, sessions will also include oral abstract presentations, selected from the highest scoring submitted abstracts. All abstracts undergo blinded peer-review by a panel of experts.
Poster presentations can be viewed during the lunchbreak.
NCHIV provides an update and platform for discussion of new insights and developments in research on the pathogenesis, epidemiology, prevention and treatment of HIV. The one-day programme has three key elements: a core programme of sessions focussed on each of these four research themes; an extended lunch programme with poster presentations; and four invited plenary speakers.
NCHIV is organised by
